Bloomberg- AGK News Stand

Bloomberg

Adani Bribery: US Case Is Bad News for India's Modi

The indictment will intensify political attacks on India’s prime minister for his proximity to the tycoon. Trump may use it to drive a hard bargain.

Pictet Sees UK as Bond Haven With Trump Tariffs Threatening EU

One of Europe’s biggest asset managers is upbeat on UK bonds, saying they will perform much better than euro-area peers after the start of Donald Trump’s second stint as US president.

BBVA Vows to Preserve Bank Access to Ease Sabadell Bid Doubts

BBVA said on Wednesday it’s committed to protect access to banking services in an effort to convince authorities that its potential takeover of rival Banco Sabadell SA wouldn’t create competition issues.

Baidu Posts Biggest Sales Decline in Two Years During Downturn

Baidu Inc. recorded its biggest revenue drop in more than two years after China’s economic malaise undermined its push into generative AI.

Exclusive: Kate Bush's Former Berkshire Home Is On Sale for £11.5 Million

The 23-acre property generates its own electricity, so there will be no running up that heating bill.

Santander Markets At Least a Dozen SRTs in Move to Boost Profits

Banco Santander SA is seeking to sell more more than a dozen significant risk transfers amid an effort to boost profitability.

Odd Arne Westad on How China First Joined the Global Capitalist Economy

The true origin of the post-Mao reforms

Pathogens Spread Further and Faster in Warming World, Study Says

More than half of human pathogens may be aggravated by climate change and this is accelerating disease transmission, according to a new report.

Frasers Calls for Removal of Boohoo Director Mahmud Kamani

Billionaire Mike Ashley’s Frasers Group Plc urged shareholders of Boohoo Group Plc to remove the fast-fashion company’s co-founder as a director, in the latest spat between two of the UK’s most prominent retail tycoons.

China Vows to Bolster Gene Therapy Research in Key Biotech Hub

China has pledged to encourage more research in gene and cell therapies at the country’s biotech hub in the eastern Chinese city of Suzhou, in the latest bid to bolster the country’s standing at the cutting edge of global drug research.